Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.7 - $37.13 $115,500 - $556,950
-15,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$26.46 - $37.15 $396,900 - $557,250
-15,000 Reduced 50.0%
15,000 $40,000
Q1 2021

May 04, 2021

BUY
$40.39 - $56.73 $395,822 - $555,954
9,800 Added 48.51%
30,000 $124,000
Q4 2020

Feb 08, 2021

BUY
$51.77 - $66.18 $269,204 - $344,136
5,200 Added 34.67%
20,200 $11,000
Q3 2020

Nov 03, 2020

BUY
$43.8 - $58.16 $657,000 - $872,400
15,000 New
15,000 $11,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.